Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
NOVA1 encodes a neuron-specific RNA-binding protein, a member of the Nova family of paraneoplastic disease antigens, that is recognized and inhibited by paraneoplastic antibodies. Zusätzlich bieten wir Ihnen NOVA1 Antikörper (76) und NOVA1 Proteine (10) und viele weitere Produktgruppen zu diesem Protein an.
overexpression of miR (zeige MLXIP ELISA Kits)-203a-3p leads to a decrease of NOVA1, counter-balanced by an increase of IKAP (zeige IKBKAP ELISA Kits), supporting a potential interaction between NOVA1 and IKAP (zeige IKBKAP ELISA Kits).
NOVA1 suppression was frequently noted in the gastric cancer microenvironment, and attenuated NOVA1 expression in tumor cells was associated with tumor progression and poor prognosis.
Nova1 interacts with GABAARgamma2 not only in the central nervous system but also in hepatocellular carcinoma. Nova1's potential mechanism as an oncogene (zeige RAB1A ELISA Kits) may due to its interaction with GABAA (zeige GABRg1 ELISA Kits) Rgamma2.
Loss of NOVA1 is associated with gastric cancer.
Quantitative proteomic analysis was performed to help elucidate a molecular distinction between glioblastoma and oligodendroglioma; analysis showed HSPB1 (zeige HSPB1 ELISA Kits) and NOVA1 to be discriminating factors.
Data indicate RNA binding protein (zeige PTBP1 ELISA Kits) NOVA1 as a target of microRNA miR (zeige MLXIP ELISA Kits)-339.
MiR (zeige MLXIP ELISA Kits)-181b-5p is a tumor suppressor in astrocytoma that inhibits tumor progression by targeting NOVA1.
High expression of NOVA1 correlates with poor prognosis in hepatocellular carcinoma.
a regulation of LEDGF (zeige PSIP1 ELISA Kits) interaction with chromatin by cellular partners of its PWWP domain could be involved in several processes linked to LEDGF (zeige PSIP1 ELISA Kits) tethering properties, such as lentiviral integration, DNA repair or transcriptional regulation
Gene silencing and overexpression of the nELAV member HuD (zeige ELAVL4 ELISA Kits) in motoneuronal NSC34 cells indicate that Nova1 mRNA stability and translation are positively and strongly controlled by the nELAV proteins
Together, these results demonstrate that the production of DCC (zeige DCC ELISA Kits) splice variants controlled by NOVA (zeige HNRNPK ELISA Kits) has a crucial function during many stages of commissural neuron development.
Phenotypic analysis of the NOVA (zeige HNRNPK ELISA Kits)-deficient mice demonstrated increased adipose tissue thermogenesis and improved glycemia.
RBM4a (zeige RBM4 ELISA Kits) ablation enhanced the relative level of exon 4-excluded neuro-oncological ventral antigen 1 (Nova1(-4)) transcripts, which were predominantly generated in embryonic BAs
identify Nova-1 and hnRNP M (zeige HNRNPM ELISA Kits) as D2R (zeige DRD2 ELISA Kits) pre-mRNA-binding proteins and show their antagonistic role in the alternative splicing of D2R (zeige DRD2 ELISA Kits) pre-mRNA.
integrative network revealed combinatorial regulation by Nova (zeige HNRNPK ELISA Kits) and the neuronal splicing factor (zeige SLU7 ELISA Kits) Fox, interplay between phosphorylation and splicing, and potential links to neurologic disease
Nova (zeige HNRNPK ELISA Kits) regulates GABA(A) receptor gamma2 alternative splicing via a distal downstream UCAU-rich intronic splicing enhancer
CLIP (cross-linking and immunoprecipitation) reveals Nova (zeige HNRNPK ELISA Kits) coordinately regulates a biologically coherent set of RNAs encoding multiple components of the inhibitory synapse, an observation that may relate to the cause of abnormal motor inhibition in POMA
These studies demonstrate that in addition to its previously described role as a splicing activator, Nova-1 autoregulates its own expression by acting as a splicing repressor.
Assays of splicing intermediates of Nova (zeige HNRNPK ELISA Kits)-regulated transcripts in mouse brain revealed that Nova (zeige HNRNPK ELISA Kits) preferentially regulates removal of introns harbouring (or closest to) YCAY clusters
This gene encodes a neuron-specific RNA-binding protein, a member of the Nova family of paraneoplastic disease antigens, that is recognized and inhibited by paraneoplastic antibodies. These antibodies are found in the sera of patients with paraneoplastic opsoclonus-ataxia, breast cancer, and small cell lung cancer. Alternatively spliced transcripts encoding distinct isoforms have been described.
neuro-oncological ventral antigen 1
, lipid A export ATP-binding/permease protein
, RNA-binding protein Nova-1
, onconeural ventral antigen 1
, paraneoplastic Ri antigen
, ventral neuron-specific protein 1